| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/31/1996 | EP0723439A1 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
| 07/31/1996 | EP0723398A1 Superoxide dismutase and mimetics thereof |
| 07/31/1996 | EP0473612B1 Fertility enhancement |
| 07/30/1996 | US5541220 Skin disorders, wound healing agents, antiinflammatory agents and radiation resistance |
| 07/30/1996 | US5541209 Method of treating or preventing cardiac arrhythmia employing an N-substituted heterocyclic derivative |
| 07/30/1996 | US5541208 Potassium channel antagonist, alzheimer*s disease and cognition activators |
| 07/30/1996 | US5541206 Retroviral protease inhibiting compounds |
| 07/30/1996 | US5541073 Method of diagnosing epidermis differentiation disorders in a patient using a stratum corneum-specific antibody |
| 07/30/1996 | US5540931 Antiinflammatory agents using lanolin, oil, polysorbates and cyclosporins |
| 07/30/1996 | US5540930 Nonagglomerating suspension |
| 07/30/1996 | US5540919 Method for enhancement of production of lymphokines and applications thereof |
| 07/30/1996 | US5540918 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions |
| 07/25/1996 | WO1996022101A1 Combined therapeutical treatment of hyperproliferative diseases |
| 07/25/1996 | WO1996022099A1 Ophthalmic compositions for treating glaucoma |
| 07/25/1996 | WO1996022019A1 Diet compositions to treat ascites in domestic animals |
| 07/25/1996 | WO1996006639A3 Novel drugs containing chelate-forming agents |
| 07/24/1996 | EP0722735A1 Parathyroid hypertensive factor |
| 07/24/1996 | EP0722722A1 Use of an antagonist of substance P for the treatment of cutaneous erythema of neurogenic origin |
| 07/24/1996 | EP0722715A1 Cosmetic compositions containing lactate dehydrogenase inhibitors |
| 07/24/1996 | EP0722342A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 07/24/1996 | EP0722324A1 Pharmaceutical composition for immunoenhancement therapy |
| 07/24/1996 | EP0722320A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 07/24/1996 | EP0722316A1 New emulsion formulation |
| 07/24/1996 | EP0722312A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 07/24/1996 | EP0714300A4 Methods for modulating the human sexual response |
| 07/24/1996 | CN1127140A Cosmetic and skin-usefull composition containing water from hot spring, mineral water and agent against acne and oldening |
| 07/23/1996 | US5539122 Retroviral protease inhibiting compounds |
| 07/23/1996 | US5538992 Potentiation of drug response |
| 07/23/1996 | US5538982 Medical use for tachykinin antagonists |
| 07/23/1996 | US5538966 Carbonic anhydrase inhibitors |
| 07/18/1996 | WO1996021466A1 Method to prevent transplant rejection |
| 07/18/1996 | WO1996021436A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products |
| 07/18/1996 | WO1996021421A1 Nutrient medium for use as a culture medium for epidermal cells, and uses thereof |
| 07/18/1996 | WO1996021416A2 Methods and compositions for treatment of solid tumors in vivo |
| 07/18/1996 | WO1996003122A3 Use of gabapentin in the treatment of anxiety and panic |
| 07/18/1996 | WO1996001253A3 PLA2 inhibitors and their use for inhibition of intestinal cholesterol absorption |
| 07/18/1996 | CA2210390A1 Improved therapeutic compositions comprising bactericidal/permeability-increasing (bpi) protein products |
| 07/17/1996 | EP0721586A1 Methods and compositions for treatment of bcr-abl associated leukemias and other cell proliferative disorders |
| 07/17/1996 | EP0721501A1 Pharmaceutical composition comprising phosphatase or a derivative thereof |
| 07/17/1996 | EP0721347A1 Agent against sensitive, hyperreactive and hypoactive states of the skin, forms of acne, atopic dermatitides, psoriasis, prurigo, photodermatoses, ichthyosis and viral infections |
| 07/17/1996 | EP0721337A1 Oral formulations of an antifungal |
| 07/17/1996 | EP0721330A1 Pharmaceutical composition |
| 07/11/1996 | WO1996021026A1 POLYMERASE δ MUTATIONS IN COLORECTAL TUMORS WITH REPLICATION ERRORS |
| 07/11/1996 | WO1996021000A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 07/11/1996 | WO1996020733A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 07/11/1996 | WO1996020728A1 Antitumor agent potentiator comprising il-6 antagonist |
| 07/11/1996 | WO1996020723A1 Controlling traf-mediated signals |
| 07/11/1996 | WO1996020718A2 Composition for inhibiting intimal hyperplasia using pdgf antagonists and heparin |
| 07/11/1996 | WO1996020709A1 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals |
| 07/11/1996 | WO1996020708A1 Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine |
| 07/11/1996 | WO1996020703A1 Compounds for veterinary and medicinal applications |
| 07/11/1996 | WO1996020701A1 Apoptosis-modulating composition comprising a factor affecting the intracellular rate of methional or malondialdehyde |
| 07/11/1996 | WO1996020698A2 Surface-modified nanoparticles and method of making and using same |
| 07/11/1996 | CA2209226A1 Polymerase .delta. mutations in colorectal tumors with replication errors |
| 07/11/1996 | CA2208986A1 Prevention of adverse behaviour, diarrhoea, skin disorders and infections of the hind gut associated with acidic conditions in humans and animals |
| 07/11/1996 | CA2207974A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 07/11/1996 | CA2207961A1 Surface-modified nanoparticles and method of making and using same |
| 07/10/1996 | EP0720620A1 Glutathione analogs and paralog panels comprising glutathione mimics |
| 07/10/1996 | EP0720481A1 Uses of vegetable oils |
| 07/10/1996 | EP0720477A1 Method and compositions for maintaining glomerular filtration rate while inhibition extracellular matrix accumulation |
| 07/10/1996 | EP0668727B1 Method for enhancing bioavailability of beta-carotene |
| 07/10/1996 | CN1126469A HIV protease inhibitors useful for the treatment of aids |
| 07/10/1996 | CN1032256C Method for preparation and use of 1 alpha, 24 dihydroxy vitamin D2 |
| 07/09/1996 | US5534410 TATA-binding protein associated factors drug screens |
| 07/04/1996 | WO1996020010A1 Combination for reducing antimicrobial resistance using a methylation inhibitor in combination with an antibiotic |
| 07/04/1996 | WO1996020009A1 Use of a tachykinin antagonist and an opioid analgesic |
| 07/04/1996 | WO1996019997A1 Compounds with progesterone-antagonistic and anti-oestrogen properties intended for combined use in female contraception |
| 07/04/1996 | WO1996019975A1 Transdermal resorption of active substances from supercooled masses |
| 07/04/1996 | WO1996019918A1 Plasma expanders and blood substitutes |
| 07/04/1996 | CA2208321A1 Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception |
| 07/04/1996 | CA2207650A1 Use of a tachykinin antagonist and an opioid analgesic |
| 07/03/1996 | EP0719546A1 LUV comprising saturated phospholipids and method of making the same |
| 07/03/1996 | EP0719331A1 Eotaxin = eosinophil chemotactic cytokine |
| 07/03/1996 | EP0719295A1 Polymeric matrices and their uses in pharmaceutical compositions |
| 07/03/1996 | EP0719156A1 Compositions containing an amino acid salt of propionic acid non-steroidal anti-inflammatory agent and at least one of a decongestant, an expectorant, an antihistamine and an antitussive |
| 07/03/1996 | EP0719145A1 Nitric oxide donor composition and method for treatment of anal disorders |
| 07/03/1996 | EP0673653A4 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it. |
| 07/03/1996 | EP0673652A4 Biologically active agent having immunomodulating properties, method for its obtaining and pharmaceutical preparation based on it. |
| 07/03/1996 | EP0669836B1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 07/03/1996 | EP0472598B1 Dry powder inhalation device |
| 07/03/1996 | CN1125573A The use of asymmmetric membranes in delivery devices |
| 07/02/1996 | US5532415 Monoamine oxidase inhibitors; parkinson's disease, nervous system disorders; cognition activators |
| 07/02/1996 | US5532268 Increasing the serotonin, norepinephrine and dopamine in the brain using fluoxetine and alprenolol, spiperone, tetratolol and propranolol |
| 07/02/1996 | US5532264 Potentiation of venlafaxine, milnacipran and duloxetine to increase available serotonin, norepinephrine and dopamine in the brain by administering oxyalkylamine derivatives |
| 07/02/1996 | US5532250 Administering a serotonin 1a receptor antagonist: alprenolol, pindolol, propranolol, or tertatolol, with fluoxetine, venlafaxine, milnacipran ro duloxetine |
| 07/02/1996 | US5532244 Potentiation of drug response |
| 07/02/1996 | US5532221 Ionically crosslinked carboxyl-containing polysaccharides for adhesion prevention |
| 07/02/1996 | US5532001 Stimulation of tanning by DNA fragments or single-stranded DNA |
| 07/02/1996 | US5531984 Antimicrobial composition |
| 06/27/1996 | WO1996019580A2 Telomerase protein component |
| 06/27/1996 | WO1996019566A1 E2 binding proteins |
| 06/27/1996 | WO1996019499A2 Improved cyclic crf antagonists |
| 06/27/1996 | WO1996019428A1 Biocidal alcohols, their production and their use |
| 06/27/1996 | WO1996019236A1 PEPTIDE p277 ANALOGS, AND PHARMACEUTICAL COMPOSITIONS COMPRISING THEM FOR TREATMENT OR DIAGNOSIS OF DIABETES |
| 06/27/1996 | WO1996019233A2 Irrigation solution and method for inhibition of pain, inflammation and spasm |
| 06/27/1996 | WO1996019228A1 Formulations and methods for reducing skin irritation |
| 06/27/1996 | WO1996019212A1 Use of boswellic acid for treating brain tumours |
| 06/27/1996 | WO1996019211A1 Liposome eye drops |
| 06/27/1996 | WO1996019204A1 Medicated tissue paper product |
| 06/27/1996 | WO1996019186A1 Antifungal treatment of nails |